-
Je něco špatně v tomto záznamu ?
The Pros and Cons of Using Oat in a Gluten-Free Diet for Celiac Patients
I. Hoffmanová, D. Sánchez, A. Szczepanková, H. Tlaskalová-Hogenová,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
31581722
DOI
10.3390/nu11102345
Knihovny.cz E-zdroje
- MeSH
- bezlepková dieta * škodlivé účinky MeSH
- celiakie diagnóza dietoterapie imunologie MeSH
- gliadin škodlivé účinky imunologie MeSH
- hodnocení rizik MeSH
- jedlá semena * škodlivé účinky klasifikace imunologie MeSH
- klinické rozhodování MeSH
- kontaminace potravin MeSH
- lidé MeSH
- nutriční hodnota MeSH
- oves * škodlivé účinky klasifikace imunologie MeSH
- výběr pacientů MeSH
- výživové doporučené dávky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
A therapeutic gluten-free diet often has nutritional limitations. Nutritional qualities such as high protein content, the presence of biologically active and beneficial substances (fiber, beta-glucans, polyunsaturated fatty acids, essential amino acids, antioxidants, vitamins, and minerals), and tolerance by the majority of celiac patients make oat popular for use in gluten-free diet. The health risk of long-time consumption of oat by celiac patients is a matter of debate. The introduction of oat into the diet is only recommended for celiac patients in remission. Furthermore, not every variety of oat is also appropriate for a gluten-free diet. The risk of sensitization and an adverse immunologically mediated reaction is a real threat in some celiac patients. Several unsolved issues still exist which include the following: (1) determination of the susceptibility markers for the subgroup of celiac patients who are at risk because they do not tolerate dietary oat, (2) identification of suitable varieties of oat and estimating the safe dose of oat for the diet, and (3) optimization of methods for detecting the gliadin contamination in raw oat used in a gluten-free diet.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005830
- 003
- CZ-PrNML
- 005
- 20200518132126.0
- 007
- ta
- 008
- 200511s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/nu11102345 $2 doi
- 035 __
- $a (PubMed)31581722
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Hoffmanová, Iva $u 2nd Department of Internal Medicine, University Hospital Královské Vinohrady and Third Faculty of Medicine, Charles University, Ruská 87, 10000 Prague, Czech Republic. iva.hoffmanova@fnkv.cz.
- 245 14
- $a The Pros and Cons of Using Oat in a Gluten-Free Diet for Celiac Patients / $c I. Hoffmanová, D. Sánchez, A. Szczepanková, H. Tlaskalová-Hogenová,
- 520 9_
- $a A therapeutic gluten-free diet often has nutritional limitations. Nutritional qualities such as high protein content, the presence of biologically active and beneficial substances (fiber, beta-glucans, polyunsaturated fatty acids, essential amino acids, antioxidants, vitamins, and minerals), and tolerance by the majority of celiac patients make oat popular for use in gluten-free diet. The health risk of long-time consumption of oat by celiac patients is a matter of debate. The introduction of oat into the diet is only recommended for celiac patients in remission. Furthermore, not every variety of oat is also appropriate for a gluten-free diet. The risk of sensitization and an adverse immunologically mediated reaction is a real threat in some celiac patients. Several unsolved issues still exist which include the following: (1) determination of the susceptibility markers for the subgroup of celiac patients who are at risk because they do not tolerate dietary oat, (2) identification of suitable varieties of oat and estimating the safe dose of oat for the diet, and (3) optimization of methods for detecting the gliadin contamination in raw oat used in a gluten-free diet.
- 650 12
- $a oves $x škodlivé účinky $x klasifikace $x imunologie $7 D018554
- 650 _2
- $a celiakie $x diagnóza $x dietoterapie $x imunologie $7 D002446
- 650 _2
- $a klinické rozhodování $7 D000066491
- 650 12
- $a bezlepková dieta $x škodlivé účinky $7 D055050
- 650 12
- $a jedlá semena $x škodlivé účinky $x klasifikace $x imunologie $7 D002523
- 650 _2
- $a kontaminace potravin $7 D005506
- 650 _2
- $a gliadin $x škodlivé účinky $x imunologie $7 D005903
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nutriční hodnota $7 D009753
- 650 _2
- $a výběr pacientů $7 D018579
- 650 _2
- $a výživové doporučené dávky $7 D064167
- 650 _2
- $a hodnocení rizik $7 D018570
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sánchez, Daniel $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic. sanchez@biomed.cas.cz.
- 700 1_
- $a Szczepanková, Adéla $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic. szczepankova.adela@gmail.com. First Faculty of Medicine, Charles University, Kateřinská 1660/32, 121 08 Prague, Czech Republic. szczepankova.adela@gmail.com.
- 700 1_
- $a Tlaskalová-Hogenová, Helena $u Laboratory of Cellular and Molecular Immunology, Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic. tlaskalo@biomed.cas.cz.
- 773 0_
- $w MED00189563 $t Nutrients $x 2072-6643 $g Roč. 11, č. 10 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31581722 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200518132126 $b ABA008
- 999 __
- $a ok $b bmc $g 1524688 $s 1095886
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 11 $c 10 $e 20191002 $i 2072-6643 $m Nutrients $n Nutrients $x MED00189563
- LZP __
- $a Pubmed-20200511